Life sciences and drug discovery
Screen thousands of compounds and targets in code before the lab.
Antinuous scores large compound libraries against a target in parallel and builds target cases from papers, ChEMBL and trial registries. Predicted scores are labeled, and each fact links to its source.
Use cases
Track competitor programs and trial results
Trial registries and company news change weekly, and checking them is a recurring task.
You ask
Every Monday, check for new or updated trials of GLP-1 drugs in obesity and flag any status change, new results or company filing.
What it does
- Builds a sheet of current programs from ClinicalTrials.gov, company filings and news.
- Re-runs the search on your schedule and compares it with the last run.
- Updates changed rows and adds a chart of programs by phase.
You get
A sheet that updates on a schedule and flags what changed.
Oncology3.4 %
Nervous system15 %
Metabolic19.6 %
Cardiovascular25.5 %
Vaccines33.4 %
Chance a drug program in phase 1 reaches approval, by area (2000 to 2015).
Who it's for
Medicinal chemistsScreen compounds against ChEMBL and PubChem data before you buy.
Target biologistsCollect cited evidence for a drug target in one sheet.
Protein engineersView RCSB PDB and AlphaFold structures beside your evidence.
Competitive intelligence analystsTrack competitor programs and trial results on a schedule.
Works with
PubMed
UniProt
RCSB PDB
AlphaFold DB
ChEMBL
ClinicalTrials.gov